|
Gender, M/F (%)
|
57/43
|
64/36
|
63.5/36.5
|
|
Median age, years [range]
|
66 [49–73]
|
61 [25–77]
|
61 [25–77]
|
|
Median KPS [range]
|
100 [80–100]
|
100 [60–100]
|
100 [60–100]
|
|
Median duration of disease, months [range]
|
1.4 [1–25]
|
1.5 [0–84]
|
1.5 [0–84]
|
|
Primary tumour site (%):
| | | |
|
Colon
|
86
|
67
|
69
|
|
Rectum
|
14
|
33
|
31
|
|
Previous adjuvant chemotherapy (%)
|
14
|
20
|
19
|
|
Number of involved organs (%) ≤ 2
|
100
|
93
|
94
|
|
Normal WBC at baseline (%)
|
100
|
96
|
96
|
|
Normal LDH at baseline (%)
|
57
|
49
|
50
|
|
Normal ALP at baseline (%)
|
29
|
36
|
35
|
|
EGFR status (%):a
| | | |
|
0–≤10
|
43
|
42
|
42
|
|
>10–≤20
|
14
|
13
|
14
|
|
>20–≤35
|
29
|
13
|
15
|
|
>35
|
14
|
31
|
29
|
